BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Recall of the CoStar® Paclitaxel-Eluting Coronary Stent Systems from CONOR Medsystems

Product group Non-active implants
Reference 01771/07

The manufacturer CONOR Medsystems recalls the CoStar® Paclitaxel-Eluting Coronary Stent Systems from the market. In the COSTAR II trial two different stent systems were compared. As a result, repeated revascularization procedures were more common with the CoStar® stent in comparison to the reference stent.

Recall of the CoStar® Paclitaxel-Eluting Coronary Stent Systems from CONOR Medsystems , Download_VeroeffentlichtAm_EN PDF, 412KB, File does not meet accessibility standards